Filing Details
- Accession Number:
- 0001140361-22-020274
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-05-23 16:58:51
- Reporting Period:
- 2022-05-19
- Accepted Time:
- 2022-05-23 16:58:51
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1228627 | Ocuphire Pharma Inc. | OCUP | Pharmaceutical Preparations (2834) | 113516358 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1674006 | Mina Sooch | C/O Ocuphire Pharma, Inc. 37000 Grand River Ave, Suite 120 Farmington Hills MI 48335 | President And Ceo | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-05-19 | 12,500 | $2.07 | 412,522 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2022-05-20 | 12,500 | $2.02 | 425,022 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Footnotes
- The price represents the weighted average price of the multiple transactions reported on this line. The shares were purchased at prices ranging from $2.045 to $2.10. Upon request by the SEC staff, the issuer or any securityholder of the issuer, the reporting person will provide full information regarding the number of shares purchased at each separate price.
- The price represents the weighted average price of the multiple transactions reported on this line. The shares were purchased at prices ranging from $2.015 to $2.025. Upon request by the SEC staff, the issuer or any securityholder of the issuer, the reporting person will provide full information regarding the number of shares purchased at each separate price.
Billionaire Hedge Funds
